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Urinary tract infection (UTI) is one of the most common infectious diseases at the
community level. In order to assess the adequacy of empirical therapy, the susceptibility
of antibiotics and resistance pattern of bacteria responsible for UTI in West Bengal, India,
were evaluated throughout the period of 2008–2013. The infection reports belonging
to all age groups and both sexes were considered. Escherichia coli was the most
abundant uropathogen with a prevalence rate of 67.1%, followed by Klebsiella spp.
(22%) and Pseudomonas spp. (6%). Penicillin was least effective against UTI-causing
E. coli and maximum susceptibility was recorded for the drugs belonging to fourth
generation cephalosporins. Other abundant uropathogens, Klebsiella spp., weremaximally
resistant to broad-spectrum penicillin, followed by aminoglycosides and third generation
cephalosporin.The antibiotic resistance pattern of two principal UTI pathogens, E. coli and
Klebsiella spp. inWest Bengal, appears in general to be similar to that found in other parts of
theGlobe. Higher than 50% resistancewere observed for broad-spectrumpenicillin. Fourth
generation cephalosporin and macrolides seems to be the choice of drug in treating UTIs
in Eastern India. Furthermore, improved maintenance of infection incident logs is needed
in Eastern Indian hospitals in order to facilitate regular surveillance of the occurrence of
antibiotic resistance patterns, since such levels continue to change.
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INTRODUCTION
The increasing emergence of bacterial resistance to a large num-
ber of antibiotics is causing major health concerns worldwide.
Nowadays, infectious pathogens are mostly resistant to several
antibiotics, and this undermines the ability of antibiotics to con-
trol infections (Tseng et al., 2008; Haider et al., 2010; Bahadin
et al., 2011; Nerurkar et al., 2012; Sood and Gupta, 2012). Uri-
nary tract infection (UTI), either hospital acquired or community
acquired, is one of the most common infections. An estimate of
patients suffering from UTI is around 150 million per annum
across the Globe, which may rise to 75% in the female popula-
tion by the age of 24, and 15–25% of this group will suffer from
a relapse of this disease (Hooton, 2001; Foxman, 2002; Hunstad,
2010; Mukherjee et al., 2013; Pouwels et al., 2013). The antimi-
crobial resistance epidemiological survey on cystitis (ARESC),
an international survey on antimicrobial resistance of pathogens,
demonstrated that E. coli showed high resistance to sulfonamide
SXT (double-strength trimethoprim-sulfamethoxazole) and to
ﬂuoroquinolone ciproﬂoxacin in nine European countries and
in Brazil (Schito et al., 2009). The occurrence of SXT resistance
among urinary pathogens appears extensive in the United States,
and it seems to be expected that SXT, sooner or later, will need to
be replaced by alternative therapies (Gupta et al., 2001). Despite
the fact that UTI is the third most common infection found
in India, only a few studies on UTI in this country have been
reported (Akram et al., 2007; Kothari and Sagar, 2008; Hussain
et al., 2012; Prakash and Saxena, 2013). In eastern India, UTI is a
common infection found among all ages from infants to elderly
persons. However, studies on UTI and the susceptibility pattern of
antibiotics in Eastern India are still underway, and there is exten-
sive debate on the choice of antibiotics due to the lack of clear
guidelines. Knowledge of the etiology and antibiotic susceptibility
pattern of the pathogen causing UTI is absolutely essential. In the
global as well as the national context, uropathogens treated empir-
ically with antibiotics have been regarded as a potential cause for
the emergence of antibiotic resistance among several classes of
bacteria. Although empirical antimicrobial treatment for UTI is
accepted clinically, bacteria are developing resistance to antibi-
otics faster than the development of new classes of antibiotics.
Very often clinicians prescribe broad-spectrum antibiotics instead
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of a speciﬁc antibiotic during empirical treatment, in view of the
resistance of the causative organism against the antibiotic. Antibi-
otic misuse and patients who are non-compliant or who do not
complete the course of antibiotic therapy cause an increase in
antibiotic-resistant bacteria.
In this present study, the trends of the antibiotic-resistant
uropathogens and their susceptibility toward various antibiotics
are considered. This study will further help in formulating guide-
lines for establishing a proper empirical therapy for UTIs while
awaiting culture sensitivity reports. It also reﬂects changes in the
susceptibility pattern of some of the most common uropathogens
over the years, in Eastern India, implying the need for periodic
monitoring in order to decrease the number of therapeutic fail-
ures and to boost an effort to arrest the growing occurrence of
antibiotic resistance.
MATERIALS AND METHODS
STUDY DESIGN AND AREA
The data were taken from the laboratory register of the School
of Tropical Medicine, Sanjiban Hospital, Uluberia; North Bengal
University Health Centre, Darjeeling; and several private hospitals
in Paschim Medinipur and Hooghly districts from January 2008
to July 2013. The anonymity of the patients was ensured. All data
were retrospectively collected and de-identiﬁedwhen this was nec-
essary to ensure patient conﬁdentiality. The study included all the
patients who were admitted or visited the out-patient department
in the hospital or health centre with symptoms of UTI during the
study period and then hadUTI conﬁrmed further by positive urine
culture reports. Patients who underwent treatment with another
antimicrobial within 48 h or within 24 h, receiving only a single
dose and in the presence of an appropriate positive culture, were
also excluded from the study.
ISOLATION AND IDENTIFICATION OF UROPATHOGENS
A clean-catch midstream specimen was collected in a sterile wide-
mouth leak-proof container to hold about 50 ml specimens. Using
the calibrated loop method with a loop diameter of 4 mm, 10 μl
of uncentrifuged specimen was transferred onto the agar plate
and streaked without ﬂaming the loop, for isolation, and incu-
bated at 35–37◦C for 24 h. A specimen was considered positive for
UTI when the density of the bacterium was ≥105 colony-forming
units (CFU)/ml. The single-colony type cultures were identiﬁed
using standard microbiological methods up to genus/species levels
wherever applicable.
ANTIBIOTIC SENSITIVITY TESTING
Antibiotic sensitivity testing was done following the Kirby-
Bauer disc diffusion method according to the Clinical and
Laboratory Standards Institute (CLSI) guidelines. The antibi-
otics tested were broad-spectrum penicillin, third generation
Cephalosporin, fourth generation Cephalosporin, Quinolones,
Tetracycline, Macrolides, Aminoglycosides, and Sulfonamides
(Himedia, India).
STATISTICAL ANALYSIS
The methodology used in this study was based on the con-
trolled cluster technique. The technique was used to classify the
percentage distributions of resistant capacity of the drugs into a
number of categories. The lowest percentage, 4% in this case, was
taken as susceptible and the highest (59%) was taken as highly
resistant. Windows XP based ArcGIS version 9.3 was used for
the categorization. This was applied to all the drugs used in this
study for all the 6 years 2008–2013. The polynomial trendlines,
except tetracycline, were also computed to study the nature of the
resistant capacity of each drug. These polynomial trendlines were
calculated depending on the nature of the curve drawn from the
percentage distribution of each drug in 6 years. Linear trend was
computed in the case of tetracycline. A number of polynomial
trendlines with different orders starting from 2 to 5 were gener-
ated using Microsoft Excel 2003 until the best ﬁtting trendline was
found for the nature of each drug. The main purpose of doing this
was to demonstrate the overall pattern of the data, whether it was
going up or down, and to predict the data during these 6 years and
what may happen in the future. Finally, radar plots were made to
compare the efﬁciency of each drug as a whole during 2008–2013.
These plots were also generated, through Microsoft Excel 2003,
mainly to investigate the relative strength and relative weakness in
different years, as well as to depict overall performance.
RESULTS
Urinary tract infections mostly occurred among 2- to 13- year-
old girls and 7 million acute uncomplicated infections occurred
annually among young women only in USA (Schappert, 1992).
Catheter-associated UTIs account for 40% of all hospital-acquired
infections and are themost common type of nosocomial infection.
UTIs are an important reservoir for selection and transmis-
sion of multi-drug-resistant strains (Kunin, 1997; Stamm, 1999).
In this study, the antibiotic susceptibility data of consecutive
samples from positive UTIs in a period of 6 years (Jan 2008
to June 2013) from an eastern state of India were analyzed.
All the acquired data of 19 antibiotics were classiﬁed, – seg-
regated properly as broad-spectrum penicillin, third generation
Cephalosporin, fourth generation Cephalosporin, Quinolones,
Tetracycline, Macrolides, Aminoglycosides, and Sulfonamides.
The infection report belonged to all age groups, and both
sexes were reviewed in this study. Of the total culture samples
(5476) analyzed, E. coli was the most dominant among all iso-
lated uropathogens with a prevalence rate of 67.1%, followed by
Klebsiella spp. (22%), Pseudomonas spp. (6%), Citrobacter spp.
(2%), Staphylococcus aureus (1%), and Enterococcus spp. (1%)
[Figure 1]. Interestingly, Klebsiella spp. infection in Eastern India
is increasing rapidly with time (Figure 1, inset). E. coli causes
80–90% of acute uncomplicated bacterial lower tract infections
(cystitis) in young women. It has been estimated that up to 15%
of patients with UTI are bacteremic, and that E. coli was the pre-
dominant pathogen of bacteremic gram-negative UTI, followed
by Klebsiella pneumoniae. The change in E. coli resistance patterns
to different antibiotics over the last 6 years (from 2008 to 2013)
is shown in Figure 2, and the second predominant causal organ-
ism,Klebsiella spp. for UTI in India, demonstrates the gradation of
resistance to different groups of antibiotics, as reﬂected inFigure 3.
The behavior of each drug during the period 2008–2013 is
presented in Figure 4. The equations in each sub-ﬁgure show
the trendline and the coefﬁcient of determination (R2) of the
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FIGURE 1 | Pie-chart visualization of total bacterial species, isolated in urinary tract infected patient inWest Bengal, India. Distribution (in %) of the
most frequent uropathogens and increasing incidence of Klebsiella spp. causing UTI (in inset).
FIGURE 2 | Antibiotic resistance pattern of E. coli. Change of resistance
pattern of different antimicrobials in E. coli over the last 6 years (from 2008
to 2013).
FIGURE 3 | Antibiotic resistance pattern of Klebsiella spp. Change of
resistance pattern of different antimicrobials in Klebsiella spp. over the last
6 years (from 2008 to 2013).
corresponding drug. Polynomial regression is generally used to
describe non-linear phenomena; in our case we wanted to test
the phenomenon of progression of resistance to certain groups
of antibiotics over time. It is interpreted that a trendline is most
reliable when the R2 value is at 1 or near 1. Since all the R2 val-
ues computed are >0.9, the values are not random and present a
good ﬁt to the proposed equation. This shows that a polynomial
trendline of order 4 is found to be ﬁtted for a penicillin com-
bination, fourth generation cephalosporin, aminoglycosides and
sulfonamides, while the same of order 3 is found to be ﬁtted for
third generation cephalosporin, quinolones, and macrolides.
Figure 5 explains the drug panel with a varying degree of ther-
apeutic potential in the face of emerging antibiotic resistance. The
red color indicates the drug candidate being least effective because
of high incidence of resistance shown by the uropathogens, while
the green colored drugs are the ones to which the pathogens
are most susceptible. It was found that the penicillin combina-
tion is least effectual, while the fourth generation cephalosporin
antibiotics are most effective. Overall use of tetracycline showed
a steady rise in the resistance pattern for both the uropathogens
during the study period, and use of this drug has been falling
since 2010. The resistance pattern toward quinolones was the same
from 2008 to 2013 for both the E. coli and Klebsiella spp. isolates.
Fourth generation cephalosporins have been found to be the most
effective against both the pathogens. However, a slight increase
in cephalosporin-resistant uropathogens was noted in the year
2013.
The radar graph shown in Figure 6 illustrates the degree of
group similarity in terms of increasing resistance toward themem-
bers of the group constituted by Penicillin combinations, fourth
generation and third generation cephalosporins. Interestingly, R2
values in polynomial regression of the members of this group are
0.9958, 0.995, and 0.941 respectively. UTI pathogens exhibited
high resistance toward the Penicillin combination in each year,
compared to that of other drugs. Emergence of antibiotic resis-
tance increased signiﬁcantly against the Penicillin combination
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FIGURE 4 |Trend analyses of the development of resistance to different antibiotics.
year after year, and it was also higher compared to that of other
drugs. Macrolide-susceptible uropathogens were found in the
years 2008–2010, when antibiotics resistant to Macrolides did not
exceed 7.27%. Most of the multiple-antibiotic-resistant pathogens
were susceptible to fourth generation cephalosporin in the years
2011–2013 (≤19.8%resistant). Uropathogens resistant tomultiple
classes of antibiotics also developed resistance toward quinolones,
macrolides, aminoglycosides, and sulfonamides (≤32% resistant),
while resistance toward the penicillin combination was found to
be as high as 59.26%.
DISCUSSION
Earlier studies from different regions of India and from other
countries have reported that the most prevalent UTI pathogen
was E. coli, followed by Klebsiella spp. (Francesco et al., 2007; Pires
et al., 2007; den Heijer et al., 2012; Mukherjee et al., 2013; Prakash
and Saxena, 2013; Renuart et al., 2013). Extended spectrum
β-lactamase (ESbL)–producing organisms causing a signiﬁcant
increase in infection outbreaks have been reported in every conti-
nent around theworld. ESbL–producing pathogens oftenmanifest
resistance determinants to several antibiotic groups like amino-
glycoside and ﬂuoroquinolones, which limit the range of effective
antibiotics (Akram et al., 2007; Mukherjee et al., 2013). The inci-
dence of ESbL-producing strains among clinical Klebsiella isolates
has been steadily increasing over recent years and accounts for
6–17% of all nosocomial UTIs (Subha and Ananthan, 2002; Hus-
sain et al., 2012). Drugs belonging to penicillin combination
were least effective (= highest incidence of resistance) against
UTI-causing E. coli from the year 2008 to 2013. It was shown
in an earlier study that MAR enterobacterial strains, isolated
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FIGURE 5 | Antibiotic sensitivity/resistance in major uropathogens of Eastern India (from 2008 to 2013). Color spectrum from green to red indicates
progressive increase in resistance. Green denotes susceptible; Red denotes alarmingly high degree of resistance.
FIGURE 6 |The radar plot. Illustration of degree of group similarity in terms of increasing resistance toward the members of the various antibiotic classes.
from West Bengal river waters, transferred R-plasmids at high
frequency to plasmid-less E. coli DH5αα strain expressing resis-
tance to ampicillin, cephalexin (ﬁrst generation cephalosporin),
and cefotaxim (third generation cephalosporin; Mukherjee and
Chakraborty, 2007). Maximum susceptibility was recorded for
the drugs belonging to fourth generation cephalosporins. Lesser
resistance to quinolones can be explained by the fact that the resis-
tance of E. coli to quinolones has remained rare until recently,
when the widespread use of quinolones as therapy for UTIs
began (Muder et al., 1991; Aguiar et al., 1992; Llordés et al.,
1993). Resistance to the penicillin combination showed a steady
increase from 2008 to 2011 followed by a slight decrease in the
years 2012 and 2013. As for the use of penicillin combinations
(the principal components, including amoxicillin, methicillin,
and piperacillin, were introduced into the Indian market from
1978 to 1989) is concerned, we have grounds to speculate that
these drugs were prescribed until quinolones and third gener-
ation cephalosporin were prescribed in the treatment of UTI.
It has been reported that individual exposure to a penicillin
combination like co-amoxiclav raises a risk for UTIs caused
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by co-amoxiclav-resistant E. coli (Leﬂon-Guibout et al., 2002).
It should also be noted that aminoglycosides, from gentam-
icin to amikacin, which were introduced within the years of
1978 to 1986, were also tried by physicians in treating UTI.
Macrolides (azithromycin, clarithromycin) can have been pre-
scribed for UTI only after they came onto the Indian market
in 1992. As per current prescribing habits of physicians treat-
ing UTI, it is most obvious to speculate that doctors would
sparingly prescribe a newly introduced generic extension within
a subgroup or a newly introduced molecule of a group. The
primary reasons are either the availability issues encountered
with a newly launched product in retail outlets and/or higher
prices of the newer generation drugs or later developed antibi-
otics. Treatment of a UTI pathogen that is resistant to all
available drugs could only be possible either by using an antibi-
otic combination or by a single antibiotic like fourth generation
cephalosporin (which appeared on the Indian scene from 2002
onwards). Cefepime, in particular, was introduced in the year
2002. The time-line of introduction of different antibiotics in
India (http://www.cdsco.nic.in/forms/Default.aspx), in treating
microbial infections including UTI, follows a similar pattern in
development of resistance toward these drugs.
Klebsiella spp. from Eastern India UTI samples were maximally
resistant to penicillin combination, followed by aminoglycosides
and third generation cephalosporin. Studies conducted in West
Bengal and around other parts of the country showed con-
sistency in Klebsiella spp., which presented the second highest
resistance after E. coli, against different classes of antibiotics;
(Kothari and Sagar, 2008). Data are consistent with the ﬁnd-
ings of a northern Indian city where K. pneumoniae showed
the highest resistance to a drug from the penicillin combina-
tion. In another study from India, which excluded the penicillin
combination in determining the resistance proﬁle of K. pneu-
moniae, it was revealed that most of the isolates were resistant
to an aminoglycoside, gentamicin, followed by third genera-
tion cephalosporin, ceftriaxone and ceftazidime (Mandal et al.,
2012).
Isolates obtained from this study have also shown maximum
resistance to aminoglycosides and third generation cephalosporin
after penicillin combination. Since penicillin combination drugs
are still the choice of physicians treating K. pneumoniae medi-
ated UTI infections, we observed increasing resistance against
such drugs from 2008 to 2013. Increasing resistance to the peni-
cillin combination can be explained by the fact that strains of K.
pneumoniae are naturally resistant to ampicillin and amoxicillin,
usually by the production of SHV-1, beta-lactamase encoded on
the chromosome or a transferable plasmid (Nugent and Hedges,
1979).
The rate of resistance is high toward the penicillin combina-
tion and tetracycline compared to other drugs, whereas the same
is less for third to fourth generation cephalosporin. The present
study also indicates that the resistance to tetracycline is increas-
ing linearly with a rate of 14.7% per year. It is also noted that the
resistant capacity of bacteria to fourth generation cephalosporin is
found to be below 19.8%, while that of the penicillin combination
and tetracycline is found to be within the range of 8.7–59.2% and
against other drugs the rates are within 3.8–32.4%.
The possible explanation of such connivance of these data
on the radar plot is that the prevalence of resistance genes ren-
ders resistance to beta-lactam and or cephalosporins due to ESbL.
The acquired data putatively supports this speculation, which will
require molecular evidence in future studies. The resistance mech-
anisms to other groups of antibiotics are so varied that they are also
reﬂected in the pattern of the individual spokes. These data also
demonstrate that except tetracycline, the resistance values against
all groups of antibiotics tested have seen a progressive increase at
the vertices of variable years, 2011–2013.
In conclusion, the antibiotic resistance pattern of two prin-
cipal UTI pathogens, E. coli and Klebsiella spp., in West Bengal,
India, appears in general to be similar to that found in other
parts of India, as well as other parts of the globe. Greater
than 50% resistance was observed for penicillin combinations.
Hence, these agents should not be used as an empiric treat-
ment for UTI in Eastern India., Fourth generation cephalosporin
and macrolides appears to be the ﬁrst choice of drugor a com-
bination of the two could be the most appropriate alternative
in treating UTIs. In addition, improved record keeping and a
prospective surveillance system are needed in the hospitals of
Eastern India in order to facilitate regular surveillance of the occur-
rence of antibiotic resistance as these levels and patterns continue
to change.
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